Sigilon Therapeutics
  • About Us
    • Our Company
      • Leadership
      • Board of Directors
      • Founders
      • Scientific Advisory Board
    • Contact Us
  • Science
    • SLTx PLatform
    • Publications
  • Pipeline
  • Patients & Caregivers
    • Overview
    • Diabetes
    • Lysosomal Diseases
  • Investors/Media
    • Investor/Media Home
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Analyst Coverage
    • Financials & Filings
      • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Leadership
      • Board of Directors
      • Committee Composition
    • Investor Relations
      • Investor FAQ
      • Email Alerts
  • Inside Sigilon
    • Our Culture
    • Job Opportunities
©2023 Sigilon Therapeutics, Inc.
sigilon logo
The marks SIGILON THERAPEUTICS, SIGILON, SHIELDED LIVING THERAPEUTICS, SLTX, AFIBROMER, AFIBROTEK, and our logos are trademarks of Sigilon Therapeutics, Inc. in the U.S. and other countries. All other marks are the property of their respective owners.     Privacy Policy